GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Xebra Brands Ltd (XCNQ:XBRA) » Definitions » Intrinsic Value: Projected FCF

Xebra Brands (XCNQ:XBRA) Intrinsic Value: Projected FCF : C$0.00 (As of Jun. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Xebra Brands Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-14), Xebra Brands's Intrinsic Value: Projected FCF is C$0.00. The stock price of Xebra Brands is C$0.07. Therefore, Xebra Brands's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Xebra Brands's Intrinsic Value: Projected FCF or its related term are showing as below:

XCNQ:XBRA's Price-to-Projected-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.575
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Xebra Brands Intrinsic Value: Projected FCF Historical Data

The historical data trend for Xebra Brands's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xebra Brands Intrinsic Value: Projected FCF Chart

Xebra Brands Annual Data
Trend Feb20 Feb21 Feb22 Feb23
Intrinsic Value: Projected FCF
- - - -

Xebra Brands Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Xebra Brands's Intrinsic Value: Projected FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Xebra Brands's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xebra Brands's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Xebra Brands's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Xebra Brands's Price-to-Projected-FCF falls into.



Xebra Brands Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Xebra Brands  (XCNQ:XBRA) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Xebra Brands's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.07/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xebra Brands Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Xebra Brands's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Xebra Brands (XCNQ:XBRA) Business Description

Traded in Other Exchanges
Address
1090 Hamilton Street, Vancouver, BC, CAN, V6B 2R9
Xebra Brands Ltd is focused on cannabis cultivation and products, with global brands and intellectual property. Its products cover wellness and leisure and include beverages. It has one reportable business segment, being the cultivation, processing, manufacturing, design and delivery of cannabis products.

Xebra Brands (XCNQ:XBRA) Headlines

No Headlines